David M. Knott Jr’s Travere Therapeutics TVTX Stock Holding History

David M. Knott Jr’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.37M	Buy	147,282 +6,649	+5%	+$295K	4.42%	5
2026 Q1	$4.18M	Sell	140,633 -45,367	-24%	-$1.36M	2.49%	12
2025 Q4	$7.11M	Sell	186,000 -74,000	-28%	-$2.41M	3.29%	6
2025 Q3	$6.21M	Hold	260,000	–	–	2.51%	9
2025 Q2	$3.85M	Buy	260,000 +32,000	+14%	+$530K	1.74%	10
2025 Q1	$4.09M	Hold	228,000	–	–	1.93%	11
2024 Q4	$3.97M	Sell	228,000 -30,231	-12%	-$535K	1.44%	12
2024 Q3	$3.61M	Sell	258,231 -7,735	-3%	-$80.6K	1.27%	19
2024 Q2	$2.19M	Buy	265,966 +35,000	+15%	+$236K	0.87%	25
2024 Q1	$1.78M	Buy	230,966 +9,961	+5%	+$84K	0.63%	31
2023 Q4	$1.99M	Buy	221,005 +120,688	+120%	+$879K	0.76%	23
2023 Q3	$897K	Buy	+100,317	New	+$1.42M	0.34%	40

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott Jr's TVTX Position: Q2 2026 in Review

David M. Knott Jr increased its Travere Therapeutics (TVTX) stake by 4.7% in Q2 2026, buying an estimated $295K and bringing the position to 147,282 shares worth $8.37M. The position accounts for 4.42% of the portfolio, ranked #5.

David M. Knott Jr first reported a position in TVTX in Q3 2023 and has held it in 12 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

David M. Knott Jr held 147,282 shares of Travere Therapeutics worth $8.37M as of Q2 2026.
David M. Knott Jr bought 6,649 Travere Therapeutics shares in Q2 2026, an estimated $295K.
Travere Therapeutics made up 4.42% of David M. Knott Jr's portfolio in Q2 2026, its #5 holding.
David M. Knott Jr first reported a position in Travere Therapeutics in Q3 2023 and has held it in 12 quarters since.
320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.